Substance replacement therapy in the context of the COVID-19-pandemic in Québec: Clinical guidance for prescribers

This guidance provides clinical guidance to prescribers to help them support people who use substances to reduce the risks they face, and to enable physical distancing and self-isolation measures, where possible, in order to reduce and prevent the spread of COVID-19.